Cpg boosts peptide-based oral immunotherapy in mice with peanut allergy
{{output}}
Background: Effective therapies for peanut allergy (PA) remain limited. Cytosine-phosphate-guanine oligodeoxynucleotides (CpG ODN) have emerged as promising adjuvants for allergen-specific immunotherapy (AIT). This study aimed to... ...
